German drug regulator has hailed the European Medicine Agency's decision to suspend the marketing authorisation of more than 700 generic drugs subjected to clinical trials by India's GVK Biosciences. The decision is being seen as the EU's determination to maintain high ethical and medical standards for approval of medicines. The EU drug regulator's announcement is also an endorsement of the Federal Institute for Drugs and Medical Devices' (BfArM) ...Tuesday 27 January 2015
German Regulator Hails EMA's Generic Drugs Suspension on GVK Bio Data
German drug regulator has hailed the European Medicine Agency's decision to suspend the marketing authorisation of more than 700 generic drugs subjected to clinical trials by India's GVK Biosciences. The decision is being seen as the EU's determination to maintain high ethical and medical standards for approval of medicines. The EU drug regulator's announcement is also an endorsement of the Federal Institute for Drugs and Medical Devices' (BfArM) ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment